Navigation Links
UT scientist receives hemophilia research award
Date:7/2/2009

Keri Smith, Ph.D., an assistant professor of pathology and laboratory medicine at The University of Texas Health Science Center at Houston, has received a Career Development Award from the National Hemophilia Foundation.

The award will support Smith's research into the development of a therapy for people with Hemophilia A, a bleeding disorder, whose immune systems are resistant to treatment. Hemophilia A affects about one in every 5,000 males born in the United States.

Through the award, Smith is eligible for up to $70,000 per year for a maximum of three years. The National Hemophilia Foundation is a nonprofit organization founded in 1948 to find cures for bleeding disorders.

People with Hemophilia A are born with a shortage of a blood-clotting protein called Factor VIII and current treatments include injections of synthetically-produced, replacement Factor VIII. Symptoms include uncontrolled, sometimes unprompted bleeding.

Nearly one in three people with Hemophilia A have immune systems that are resistant to replacement Factor VIII and produce antibodies that attack the synthetic protein. "Current therapies to treat these antibodies are expensive and often unsuccessful," Smith said.

Smith's solution is to alter the chemical signals produced by T cells that trigger the production of the anti-Factor VIII antibodies in people with Hemophilia A, which in turn would make people with the disease more receptive to the replacement protein.

"The real advances in science often occur at the interface between two different fields," said Steven J. Norris, Ph.D., Robert Greer Professorship in the Biomedical Sciences and vice chair for research in the Department of Pathology and Laboratory Medicine at The University of Texas Medical School at Houston. "In this case, Dr. Smith has applied her expertise in T cells and their role in inflammatory reactions to an important problem in the treatment of hemophilia with Factor VIII. She will first look for inflammatory responses to Factor VIII, and then see if they can be blocked by using a novel protein that inhibits such responses. This approach may decrease the occurrence of inhibitory antibodies that often interfere with an otherwise effective treatment for hemophilia."

Smith's hemophilia research also received support through the Center for Clinical and Translational Sciences at the UT Health Science Center. Smith completed her undergraduate work at The University of Delaware, her doctorate at Montana State University and her postdoctoral training at The University of Michigan.


'/>"/>

Contact: Robert Cahill
Robert.Cahill@uth.tmc.edu
713-500-3030
University of Texas Health Science Center at Houston
Source:Eurekalert

Related biology news :

1. UK scientists working to help cut ID theft
2. Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes
3. Comet probes reveal evidence of origin of life, scientists claim
4. Scientists link fragile X tremor/ataxia syndrome to binding protein in RNA
5. Male elephants get photo IDs from scientists
6. Scientists retrace evolution with first atomic structure of an ancient protein
7. Muscle mass: Scientists identify novel mode of transcriptional regulation during myogenesis
8. Carnegie Mellon scientists develop nanogels that enable controlled delivery of carbohydrate drugs
9. Clemson scientists shed light on molecules in living cells
10. Scientists tackle mystery mountain illness
11. T. rex quicker than Becks, say scientists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/11/2017)... 11, 2017 Research and Markets has announced ... report to their offering. ... global eye tracking market to grow at a CAGR of 30.37% ... Tracking Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
(Date:4/5/2017)...  The Allen Institute for Cell Science today announces ... portal and dynamic digital window into the human cell. ... application of deep learning to create predictive models of ... a growing suite of powerful tools. The Allen Cell ... publicly available resources created and shared by the Allen ...
(Date:4/3/2017)... , April 3, 2017  Data ... precision engineering platform, detected a statistically significant ... product prior to treatment and objective response ... the potential to predict whether cancer patients ... to treatment, as well as to improve ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... of a complex biological network, a depiction of a system of linkages and ... Dmitry Korkin, PhD, associate professor of computer science at Worcester Polytechnic Institute (WPI) ...
(Date:10/12/2017)... ... October 12, 2017 , ... AMRI, a ... biotechnology industries to improve patient outcomes and quality of life, will now be ... are being attributed to new regulatory requirements for all new drug products, including ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is ... and 8th June 2018 in San Francisco, CA. The Summit brings together current and ... distinguished CEOs, board directors and government officials from around the world to address key ...
(Date:10/11/2017)... ... October 11, 2017 , ... A new ... rates in frozen and fresh in vitro fertilization (IVF) transfer cycles. ... to IVF success. , After comparing the results from the fresh and frozen ...
Breaking Biology Technology: